Ajanta Pharma Ltd (AJANTPHARM) — Insider Trading | 27 August 2026
Ajanta Pharma Ltd disclosed that promoter group entities including Yogesh Agrawal Trust, Rajesh Agrawal Trust, and Ravi Agrawal Trust released pledges on 19-Aug-26 against RBL Bank loans, reducing encumbered shares from 10.05% to 10.79% of total capital. Concurrently, Ganga Exports created a new pledge on 21-Aug-26 for 0.74% of shares as additional security. The filing confirms promoter holdings remain unchanged at 14.47% each across three trusts, with no new encumbrances affecting overall promoter stake. [amount not verified] and [amount not verified] were repaid on the repayment date, while ₹30,000 shares were pledged with 360 One Prime Ltd.
About Ajanta Pharma Ltd (AJANTPHARM)
Healthcare · Pharmaceuticals · Listed on BSE
📡 Get AI alerts when AJANTPHARM files next
Free • Daily 5 PM digest • Track filings, board meetings, and corporate actions
Track AJANTPHARM — Free💡 Ask AI about this filing
📊 More AJANTPHARM filings
- Announcement — 31 August 2026 Ajanta Pharma announced its schedule for upcoming investor meetings with Jefferies India Forum on Se...
- Announcement — 5 August 2026 Ajanta Pharma announced its schedule for analyst and institutional investor meetings in August 2026,...
- Announcement — 3 August 2026 Ajanta Pharma announced that a written transcript of its Q1 FY26 earnings call held on July 30, 2026...
- Announcement — 30 July 2026 Ajanta Pharma announced that its Nomination and Remuneration Committee allotted 23,400 equity shares...
- 🔴 Corporate Action — 30 July 2026 Ajanta Pharma announced that August 5, 2026 will be the record date for determining shareholders eli...
🔥 Also filed on 27 August 2026
Source: Stock Announcements. Analysis by StockFin.ai. For informational purposes only — not investment advice.
Editorial & Data Transparency Notice
This analysis was programmatically compiled using StockFin AI utilizing official regulatory disclosures from the BSE and NSE. Content is automatically synthesized and audited against public financial filings. StockFin.ai is an educational research platform and is NOT a SEBI-registered investment advisor or research analyst.
📡 Get AI alerts when AJANTPHARM files new disclosures
Track AJANTPHARM filings, board meetings, and corporate actions. Free email alerts at 5 PM.
Track AJANTPHARM — FreeFree account · 2 AI queries/day
© 2026 StockFin.ai — AI-powered Indian stock research
About · Privacy Policy · Terms of Service · Pricing
Today's Announcements · Screener · Insights · AI Chat
Data provided by CMOTS Internet Technologies Pvt Ltd